US equities
|
NVDA
$239.24
▲+0.14%
MU
$1,045.56
▼-1.73%
SPCX
$171.92
▲+0.49%
AMD
$649.42
▲+2.80%
MRVL
$287.01
▲+5.81%
AVGO
$375.81
▲+3.67%
INTC
$112.50
▼-3.18%
MSFT
$529.30
▲+0.78%
NVDA
$239.24
▲+0.14%
MU
$1,045.56
▼-1.73%
SPCX
$171.92
▲+0.49%
AMD
$649.42
▲+2.80%
MRVL
$287.01
▲+5.81%
AVGO
$375.81
▲+3.67%
INTC
$112.50
▼-3.18%
MSFT
$529.30
▲+0.78%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Qscreen AI Inc
(OP:
PMEDF
)
0.0169
+0.0030 (+21.58%)
Delayed Quote
Updated: 2:48 PM EDT, Oct 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Qscreen AI Inc
< Previous
1
2
3
Next >
Predictmedix Receives Purchase Order Valued at $500k from MGM Healthcare for AI-Powered Safe Entry Stations to Enhance Healthcare Operations
March 30, 2023
Via
ACCESSWIRE
Predictmedix’s Safe Entry Receives International Recognition in Major Indonesian Newspaper for its Healthcare Application
March 28, 2023
Via
ACCESSWIRE
Predictmedix Expands on Non-Invasive AI-powered Impairment Detection Technology for Vertical-Specific Applications
March 23, 2023
Via
ACCESSWIRE
Predictmedix Announces US Patent Grant for AI-Powered Impairment Detection Technology for Cannabis and Alcohol Screening
March 21, 2023
Via
ACCESSWIRE
Predictmedix Deploys Safe Entry's Fit for Duty Screening at LongArm Engineering
November 17, 2022
Via
ACCESSWIRE
Predictmedix Announces Production of AI-Powered Mobile Application to Rapidly Detect Impairment from Alcohol and Cannabis
March 15, 2023
Via
ACCESSWIRE
Predictmedix Announces Completion of 1600-Person Clinical Study for Safe Entry's Medical Device Regulatory Approval in Indonesia
March 08, 2023
Via
ACCESSWIRE
Predictmedix Announces a Purchase Order for Safe Entry's Fit for Duty Screening in the Defence Sector
March 06, 2023
Via
ACCESSWIRE
Predictmedix Announces Third-Party Independent Clinical Validation for AI-Powered Screening following 400 Patient Study at MGM Healthcare
February 15, 2023
Via
ACCESSWIRE
Predictmedix Closes $612,500 Private Placement and Announces Listing on the Frankfurt Exchange
February 13, 2023
Via
ACCESSWIRE
Predictmedix Provides Corporate Update on Key Technology Milestones and Commercialization Outlook for 2023
January 16, 2023
Via
ACCESSWIRE
Predictmedix Provides Business and Technology Development Updates and Closes Final Tranche of Private Placement
November 07, 2022
Via
ACCESSWIRE
Predictmedix Closes First Tranche of Private Placement
August 22, 2022
Via
ACCESSWIRE
Predictmedix and Partners Launch Safe Entry Station as a Comprehensive Fit for Duty Screening Solution at Electra Mining Africa and National Safety Council's (NSC) Congress & Expo
August 08, 2022
Via
ACCESSWIRE
Predictmedix Announces Accuracy Rates for Monitoring of Symptoms and Physiological Parameters
July 25, 2022
TORONTO, ON / ACCESSWIRE / July 25, 2022 / Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) ("Predictmedix" or the "Company"), an emerging provider of rapid health screening solutions powered by a...
From
Predictmedix
Via
AccessWire
Topics
Artificial Intelligence
Predictmedix Announces Accuracy Rates for Monitoring of Symptoms and Physiological Parameters
July 25, 2022
Via
ACCESSWIRE
Predictmedix Receives $1.85 Million Letter of Intent for 80 Safe Entry Stations from KaTron Defence Space and Simulation Technologies
June 29, 2022
TORONTO, ON / ACCESSWIRE / June 29, 2022 / Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) ("Predictmedix" or the "Company"), an emerging provider of rapid health screening solutions powered by a...
From
Predictmedix
Via
AccessWire
Topics
Artificial Intelligence
Cannabis
EXCLUSIVE: Predictmedix Receives $1.85M LOI For 80 Safe Entry Stations From KaTron Defence Space And Simulation Technologies
↗
June 29, 2022
Predictmedix Inc. (CSE: PMED) (OTCQB: PMEDF), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI) has received a non-binding Letter of Intent
Via
Benzinga
Emerging Technologies Are Advancing The Urgent Need For Noninvasive Cannabis Impairment Detection
↗
June 28, 2022
By Dr. Rahul Kushwah, Interim CEO, Predictmedix
Via
Benzinga
Predictmedix Secures Deployment of Safe Entry Stations at De Beers Forevermark Forum 2022
June 15, 2022
High Visibility, Revenue Generating Deployment Provides Predictmedix with Strong Industry Validation
From
Predictmedix
Via
AccessWire
Topics
Artificial Intelligence
Predictmedix Reports Fiscal 2022 Financial Results
June 01, 2022
TORONTO, ON / ACCESSWIRE / June 1, 2022 / Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) ("Predictmedix" or the "Company"), an emerging provider of rapid health screening solutions powered by a proprietary...
From
Predictmedix
Via
AccessWire
Topics
Artificial Intelligence
Cannabis
Predictmedix to Present at 12th Annual LD Micro Invitational
May 24, 2022
Interim CEO Dr. Rahul Kushwah to Present at 11:00 a.m. Pacific on June 7, 2022
From
Predictmedix
Via
AccessWire
Topics
Artificial Intelligence
Predictmedix Showcases Safe Entry Station Technology at Major Las Vegas Entertainment Event
April 05, 2022
Placement at Major Las Vegas Venue Served as Live, High-Profile Demonstration of Safe Entry Station to Area Entertainment and Hospitality Sector Representatives TORONTO, ON / ACCESSWIRE / April 5, 2022...
From
Predictmedix
Via
AccessWire
Topics
Artificial Intelligence
Predictmedix Inc. Issues Shareholder Letter and Provides Corporate Update on Key Milestone Achievements
February 10, 2022
TORONTO, ON / ACCESSWIRE / February 10, 2022 / Predictmedix Inc. (CSE:PMED)(OTCQB:PMEDF) ("Predictmedix" or the "Company"), an emerging provider of rapid health screening solutions powered by a...
From
Predictmedix
Via
AccessWire
Topics
Artificial Intelligence
Predictmedix To Launch Infectious Diseases Clinical Trial in North American Hospital for FDA Medical Device Classification of Safe Entry Stations
January 26, 2022
Independent Study for Infectious Diseases Symptom Detection in a Clinical Setting to Provide Additional Third-Party Validation; Prerequisite Ahead of Planned FDA Certification as Class II Medical...
From
Predictmedix
Via
AccessWire
Topics
Artificial Intelligence
Predictmedix Announces Accuracy Rates for Alcohol and Cannabis Impairment Detection Technology and Provides Update on the Next Steps for Technology Commercialization
January 12, 2022
Upcoming Clinical trial in North American Hospital Expected to Provide Additional Third-Party Validation Ahead of Planned Commercial Launch TORONTO, ON / ACCESSWIRE / January 12, 2022 / Predictmedix...
From
Predictmedix
Via
AccessWire
Topics
Artificial Intelligence
Cannabis
Predictmedix Secures Inaugural Placement of Safe Entry Station at Health and Wellness Retreat in Ontario, Canada
December 16, 2021
Ste. Anne's Spa, an Ontario-Based Health and Wellness Retreat, to Rollout Safe Entry Station Solution to Ensure Safe Environment for Staff & Guests Health Retreat & Resort Market Represents Significant...
From
Predictmedix
Via
AccessWire
Predictmedix Launches ThuraPass Safe Entry Program for Sports and Entertainment Industry in Conjunction with Uptown Sports Marketing
November 03, 2021
First Major Deployment at Formula One United States Grand Prix Successfully Identified COVID-19 Infected Staff Prior to Event Entry TORONTO, ON / ACCESSWIRE / November 3, 2021 / Predictmedix Inc....
From
Predictmedix
Via
AccessWire
Topics
Artificial Intelligence
Intellectual Property
Predictmedix Safe Entry Station Receives CE Mark Approval and ISO Certification for Commercialization in the European Union
November 02, 2021
Regulatory Approval Enables Commercialization in New, Leading Global Marketplaces TORONTO, ON / ACCESSWIRE / November 2, 2021 / Predictmedix Inc. (CSE:PMED)(OTCQB:PMEDF) ("Predictmedix" or the...
From
Predictmedix
Via
AccessWire
Topics
Artificial Intelligence
Intellectual Property
Predictmedix Deployed Safe Entry Stations at Formula 1 Aramco United States Grand Prix
October 25, 2021
Company Deployed 15 Safe Entry Stations at Circuit of the Americas in Austin, Texas to Screen Hospitality Suite Attendees and Catering Staff TORONTO, ON / ACCESSWIRE / October 25, 2021 / Predictmedix...
From
Predictmedix
Via
AccessWire
Topics
Artificial Intelligence
Intellectual Property
< Previous
1
2
3
Next >
